glp-1; obesity; weight loss; lifestyle

  1. madman

    FDA-Approved vs. Compounded GLP-1s: Comparing Safety, Quality, and Transparency

    The guest speakers says it all LOL! The Obesity Society (TOS) convened a panel of leading experts in obesity medicine, pharmacy, and regulatory law on March 19, 2025, to discuss the growing concerns surrounding the use of compounded GLP-1s for weight management and diabetes treatment. The...
  2. madman

    Pharma-cise™ in the Glucagon-like Peptide-1 Receptor Agonists Era

    Ross Arena, PhD, Professor and Head of the Department of Physical Therapy, College of Applied Health Sciences, at the University of Illinois at Chicago, reviews his article appearing in the December 2024 issue of Mayo Clinic Proceedings, where he finds promise in the newly emerging medical...
Back
Top